Detalhe da pesquisa
1.
HER2-Low Status Was Associated With Better Breast Cancer-Specific Survival in Early-Stage Triple-Negative Breast Cancer.
Oncologist
; 29(3): e309-e318, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769330
2.
Micro-computed tomographic evaluation of the shaping ability of three nickel-titanium rotary systems in the middle mesial canal of mandibular first molars: an ex vivo study based on 3D printed tooth replicas.
BMC Oral Health
; 24(1): 294, 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431556
3.
Dyslipidemia is associated with a poor prognosis of breast cancer in patients receiving neoadjuvant chemotherapy.
BMC Cancer
; 23(1): 208, 2023 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870942
4.
A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy.
Med Sci Monit
; 29: e940124, 2023 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37454245
5.
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial.
Lancet Oncol
; 23(3): 353-361, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085506
6.
Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR).
Ann Surg Oncol
; 28(9): 5098-5109, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33598861
7.
Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
Cell Mol Biol Lett
; 25: 43, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32983239
8.
Correction to: Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR).
Ann Surg Oncol
; 28(Suppl 3): 871, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33738721
9.
Targeted axillary dissection after neoadjuvant chemotherapy for highly selective patients with initial cN1 breast cancer: A single-center prospective trial.
Chin Med J (Engl)
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38557731
10.
Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant Chemotherapy.
Cancer Res Treat
; 55(4): 1210-1221, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37024094
11.
Impact of residual disease biomarkers on the prognosis of HER2-positive breast cancer following neoadjuvant therapy.
Cancer Med
; 12(10): 11293-11304, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951436
12.
Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial.
Nat Commun
; 14(1): 6654, 2023 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37863916
13.
Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trial.
Nat Commun
; 14(1): 6272, 2023 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37805496
14.
Novel printed electrode immunosensors for Schistosoma japonicum.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 37(6): 541-8, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22772409
15.
Exploration of prognostic factors and the value of adjuvant chemotherapy in T1a,bN0M0 triple-negative breast cancer: a prospective cohort study based on the SEER database.
Gland Surg
; 11(8): 1341-1355, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082084
16.
Optimal Frequency for Changing Single-Use Enteral Delivery Sets in Infants after Congenital Heart Surgery: A Randomized Controlled Trial.
J Am Nutr Assoc
; 41(2): 140-148, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33705273
17.
Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy Regimen.
Cancers (Basel)
; 14(18)2022 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36139667
18.
Pathological response and predictive role of tumour-infiltrating lymphocytes in HER2-positive early breast cancer treated with neoadjuvant pyrotinib plus trastuzumab and chemotherapy (Panphila): a multicentre phase 2 trial.
Eur J Cancer
; 165: 157-168, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35235873
19.
Effect of the HER-2/CEP17 ratio in IHC 2+/FISH-amplified breast cancer on pathological complete response to neoadjuvant pertuzumab and trastuzumab treatment-a retrospective cohort study.
Gland Surg
; 11(12): 1887-1896, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36654959
20.
Artificial preparation, indoor passage, and nature breed of Oncomelania hupensis infected with Schistosoma Japonicum.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 36(1): 1-8, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21311132